Lydia Poole,Ruth A Hackett
Lydia Poole
Jithin Sam Varghese,Emily N Peterson,Mohammed K Ali et al.
Jithin Sam Varghese et al.
Professional society and expert guidelines recommend the achievement of glycaemic, blood pressure, and cholesterol targets to prevent the microvascular and macrovascular complications of diabetes. The WHO Diabetes Compact recommends that co...
Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores [0.03%]
具有动态生物标志物和风险评分的1型糖尿病进展预测
Mugdha V Joglekar,Simranjeet Kaur,Flemming Pociot et al.
Mugdha V Joglekar et al.
Identifying biomarkers of functional β-cell loss is an important step in the risk stratification of type 1 diabetes. Genetic risk scores (GRS), generated by profiling an array of single nucleotide polymorphisms, are a widely used type 1 di...
David J Handelsman,Susan R Davis
David J Handelsman
Small Island Developing States: addressing the intersecting challenges of non-communicable diseases, food insecurity, and climate change [0.03%]
小岛屿发展中国家：应对非传染性疾病、粮食不安全和气候变化的交叉挑战
Cornelia Guell,Arlette Saint Ville,Simon G Anderson et al.
Cornelia Guell et al.
Small Island Developing States (SIDS) include 37 UN member countries sharing economic, environmental, and social vulnerabilities and intractable health challenges. In over 80% of SIDS, more than one in six adults die prematurely from a non-...
Perfluoroalkyl and polyfluoroalkyl substances: the price of forever chemicals [0.03%]
全氟和多氟化合物：“永久化学品”的代价
Dana L Sheinhaus,Andrea C Gore
Dana L Sheinhaus
Ray Cavanaugh
Ray Cavanaugh
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis [0.03%]
SGLT2抑制剂对心血管死亡和心力衰竭结局的改善作用——系统评价和meta分析
Muhammad Shariq Usman,Deepak L Bhatt,Ishaque Hameed et al.
Muhammad Shariq Usman et al.
Background: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have been studied in patients with heart failure, type 2 diabetes, chronic kidney disease, atherosclerotic cardiovascular disease, and acute myocardial infarc...
Lars Rydén,Anna Norhammar
Lars Rydén
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology